JosephJankovicMD

Movement Disorder

Professor of Neurology, Distinguished Chair in Movement Disorders Director, Parkinson's Disease Cent Baylor College of Medicine

Join to view full profile

Dr. Jankovic is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jankovic's full profile

Already have an account?

Office
6550 Fannin St
Ste 1801
Houston, TX 77030
Phone+1 713-798-5975

Fax+1 713-798-1898

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1974 - 1977
Baylor College of MedicineInternship, Internal Medicine, 1973 - 1974
University of Arizona College of MedicineClass of 1973
Arizona State UniversityBachelor, 1967 - 1969

Certifications & Licensure

CA State Medical License 1975 - Present
TX State Medical License 1977 - 2026
AZ State Medical License 1975 - 1996
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Lifetime Achievement Award Texas Neurological Society, 2017
Listed in Houston’s Toc Docs Houston Chronicle, 2016
Recipient of the the 35th Anniversary Award Benign Essential Blepharospasm Reseach Foundation (BEBRF), 2016
Listed in World’s Most Influential Scientific Minds 2015
Highest Score in Academic Content, Clarity of Presentation and Interest to Participants European Academy of Neurology, 2015
Best Speaker Certificate for presentations European Academy of Neurology, 2015
Recipient of the Stanley Fahn Lectureship Award presented at the Presidential Plenary Session, International Congress of Parkinson’s Disease and Movement Disorders 2014
Faculty Member of the Year Award for the Neurological Disorders Faculty F1000, 2014
Recipient of the Master Clinician Lifetime Award Baylor College of Medicine, 2014
America's Top Doctors Castle Connolly, 2002-2014
Top Doctors:SE Texas Castle Connolly, 2013
Life Fellow Texas Neurological Society, 2013
Recipient of the First Fellowship Award Dystonia Medical Research Foundation, 2012
Recognition Award for 35 years of service Baylor College of Medicine, 2012
Grand (First) prize in the Neuro Film Festival American Academy of Neurology, 2012
First price (Platinum REMI) for documentary World Fest Film Festival, 2011
Distinguished Service Award Dystonia Medical Research Foundation, 2011
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Fulbright & Jaworski Faculty Excellence Award for Teaching and Evaluation Baylor College of Medicine, 2010
Alumni Association Distinguished Faculty Award Baylor College of Medicine, 2010
Selected as Great Teacher NIH Clinical Center, 2009
Lifetime Achievement Award Tourette Syndrome Association, 2009
Marjorie Guthrie Award Northeast Ohio Chapter of the Huntington’s Disease Society of America, 2009
Guthrie Family Humanitarian Award Huntington’s Disease Society of America, 2008
Recognition Award for 30 years of service Baylor College of Medicine, 2008
Lifetime Achievement Award in recognition of significant contributions to advancing the science and understanding of botulinum toxin Allergan, 2008
Honorary Fellow American Neurological Association, 2008
Platinum (1st place) Award, International Film Festival 2007
Recognition Awards National Tourette Syndrome Association (TSA); TSA of Texas; Parkinson’s Disease Center; Movement Disorders Clinic at Baylor College of Medicine, 2007
Roy H. Cullen Quality of Life Award Houston Area Parkinson Society, 2007
Distinguished Service Award First National Parkinson Foundation, 2007
Movement Disorders Research Award, sponsored by the Parkinson’s Disease Foundation and given in recognition of outstanding achievements in Movement Disorders research American Academy of Neurology, 2007
First Prize (Platinum REMI) 40th World Fest Film Festival, 2007
Team Hope Award for Medical Leadership Huntington Disease Association of America, 2004
Winner, Neurobowl, Neurology in Movies AAN, 2004
Listed annually in Houston’s Top Docs HTexas Magazine, 2004
Listed annually in Who’s Who in American Education 2003
Listed annually in the Super Doctors Texas Monthly, 2002
Listed as a Highly Cited Researcher in recognition of ranking among the top 1% researchers for most cited documents in their specific field 2001
Listed in America’s Top Doctors Castle Connolly Medical, Ltd, 2001
Fellow Texas Neurological Society, 2000
Recipient of Honorary Diploma awarded by the Dean of the First Faculty of Medicine Charles University, 1999
Listed annually in Houston’s Best Doctors, Inside Houston 1998
Appointed and Commissioned as the “Arkansas Traveler” for distinguished accomplishments 1997
Listed annually in Who’s Who in the South and Southwest 1997
Listed annually in Who’s Who in Medicine and Healthcare 1997
Selected by the Residents as the Visiting Faculty for that Academic Year Mayo Clinic, Rochester, 1993
Listed in The Best Doctors in America Woodward and White, 1992, 1994, 1996
Listed annually in Who's Who in Science and Engineering 1992
Scientific Achievement Award in Tourette Syndrome Research Tourette Syndrome Association, 1991
Inducted into the Hall of Fame Blepharospam Research Foundation, 1991
Listed annually in Who's Who in Health and Medical Services 1991
Listed annually in Who's Who in the World 1990
Listed annually in Who's Who in America 1990
Alumni Medal University of Arizona College of Medicine, 1989
Listed as an Outstanding Medical Specialist in the U.S. in a physician survey, Town & Country 1989
Listed as Well-Known Specialist in Sunshine L. Wright JW: The Best Hospitals in America Henry Holt and Company, 1987
First Recipient of the Benign Essential Blepharospasm Research Foundation Award 1985
Listed among the top 20 most cited PD researchers Sorensen AA, Weedon D. Productivity and impact of the top 100 cited Parkinson's disease investigators, 1985
Fellow American Academy of Neurology, 1982
Physician's Recognition Award in Continuing Medical Education AMA, 1978, 1982
Favored Faculty Member Baylor College of Medicine, 1978, 1984
AED Pre-Medical Honor Society 1967
Listed in Top Doctors US News and World Report
Super Doctor SuperDoctors.com
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

A Randomized, Placebo-controlled, Tourette Syndrome Study. Start of enrollment: 2004 Sep 01
Completed
Phase 3
An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome. Start of enrollment: 2004 Oct 01
Completed
Phase 3
Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression Start of enrollment: 2010 Jun 01
Completed
Phase 2
Flu-Like Symptoms as a Complication of Botulinum Toxin Therapy Start of enrollment: 2011 Apr 01
Completed
The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias Start of enrollment: 2011 Jan 01
Completed
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Start of enrollment: 2012 Jul 01
Recruiting
Parkinson's Foundation Quality Improvement Initiative Start of enrollment: 2009 Jul 01
Completed
MER Versus MRI Guidance DBS in Parkinson's Disease Start of enrollment: 2011 May 01
Completed
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years Start of enrollment: 2014 Mar 01
Completed
Phase 2
A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia Start of enrollment: 2021 Mar 29
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

92 citations
The relationship between essential tremor and Parkinson's disease
Mary Ann Thenganatt, Joseph Jankovic
Parkinsonism & Related Disorders. 2016-01-01
418 citations
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
Robert G. Holloway, Ira Shoulson, Stanley Fahn, Karl Kieburtz, Anthony E. Lang
Archives of Neurology. 2004-07-01
322 citations
The genetics of Parkinson disease.
Hao Deng, Peng Wang, Joseph Jankovic
Ageing Research Reviews. 2018-03-01

Journal Articles

Local Field Potentials of Subthalamic Nucleus Contain Electrophysiological Footprints of Motor Subtypes of Parkinson’s Disease
Joseph Jankovic, Ashwin Viswanathan, Akshay Gupte, Aviva Abosch, Proceedings of the National Academy of Sciences
Dystonia treatment: Patterns of medication use in an international cohort
Pirio Richardson S, Wegele AR, Skipper B, Deligtisch A, Jinnah HA; Dystonia Coalition Investigators (including Jankovic J), Neurology, 1/1/2017
Treatment of blepharospasm with apraclonidine
Vijayakumar D, Wijemanne S, Jankovic J, J Neurol Sci, 1/1/2017
Letter re: Huntington disease reduced penetrance alleles occur at high frequency in the general population
Jankovic J, Squitieri F, Neurology, 1/1/2017
Counseling at-risk Parkinson's disease cohorts: Integrating emerging evidence
Sokol LL, Young MJ, Jankovic J, Curr Genet Med Rep, 1/1/2017
Research Priorities in Limb and Task-specific Dystonias
Pirio Richardson S, Altenmuller E, Alter K, Alterman RL, Chen R, Frucht S, Furuya S, Jankovic J, Jinnah HA, Kimberley TJ, Lungu C, Perlmutter JS, Prudente CN and Halle..., Front Neurol, 1/1/2017
A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease
Olanow CW, Kieburtz K, Leinonen M, Elmer L, Giladi N, Hauser RA, Klepiskaya OS, Kreitzman DL, Lew MF, Russell DS, Kadosh S, Litman P, Friedman H, Linvah N, The P B Stu..., Mov Disord, 1/1/2017
Metabolomic biomarkers as strong correlates of Parkinson disease progression
LeWitt PA, Li J, Lu M, Guo L, Auinger P; Parkinson Study Group–DATATOP Investigators (including Jankovic J), Neurology, 1/1/2017
Movement disorders induced by deep brain stimulation
Baizabal-Carvallo JF, Jankovic J, Parkinsonism Relat Disord, 1/1/2016
Genome-wide association study in essential tremoridentifies three new loci
Muller SH, Girard SL, Hopfner F, Merner ND, Bourassa CV, Lorenz D, Clark LN, Tittmann L, SotoOrtolaza AI, Klebe S, Hallett M, Schneider SA, Hodgkinson CA, Lieb W, Wszo..., Brain, 1/1/2016
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials
Huntington Study Group PHAROS Investigators, Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K,..., JAMA Neurol, 1/1/2016
Identification of TMEM230 mutations in familial Parkinson's disease
Deng HX, Shi Y, Yang Y, Ahmeti KB, Miller N, Huang C, Cheng L, Zhai H, Deng S, Nuytemans K, Corbett NJ, Kim MJ, Deng H, Tang B, Yang Z, Xu Y, Chan P, Huang B, Gao XP, ..., Nat Genet, 1/1/2016
CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study
Kang JH, Mollenhauer B, Coffey CS, Toledo JB, Weintraub D, Galasko DR, Irwin DJ, Van Deerlin V, Chen-Plotkin AS, Caspell-Garcia C, Waligorska T, Taylor P, Shah N, Pan ..., Acta Neuropathol, 1/1/2016
How do I examine for a re-emergent tremor?
Jankovic J, Mov Disord Clin Practice, 1/1/2016
Power calculations and placebo effect for future clinical trials in Progressive Supranuclear Palsy
Stamelou M, Schope J, Wagenpfeil S, del Ser T, Bang J, Lobach IY, Luong P, Respondek G, Oertel WH, Boxer AL, Hoglinger GU; for the AL-108-231 Investigators and Tauro..., Mov Disord, 1/1/2016
Submolecular recognition regions of the H(N) domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients
Oshima M, Deitiker P, Jankovic J, Atassi MZ, J Neuroimmunol, 1/1/2016
Progression of brain atrophy in PSP and CBS over 6 months and 1 year
Dutt S, Binney RJ, Heuer HW, Luong P, Attygalle S, Bhatt P, Marx GA, Elofson J, Tartaglia MC, Litvan I, McGinnis SM, Dickerson BC, Kornak J, Waltzman D, Voltarelli L, ..., Neurology, 1/1/2016
Recent advances in understanding and managing Tourette syndrome
Thenganatt MA Jankovic J, F1000Research, 1/1/2016
Leg stereotypy disorder
Jankovic J, J Neurol Neurosurg Psychiatry, 1/1/2016
Psychogenic ophthalmologic movement disorders
Baizabal-Carvallo JF, Jankovic J, J Neuropsychiatry Clin Neurosci, Summer, 1/1/2016
Data analytics from Enroll-HD, a global clinical research platform for Huntington’s disease
Landwehrmeyer GB, Fitzer-Attas CJ, Giuliano JD, , AB, BSN,2 Alves NG, Anderson KE, Cardoso F, Ferreira JJ, Mestre TA, Stout JC, Sampaio C (including Jankovic J), Mov Disord Clin Practice, 1/1/2016
Dystonia Genetic Consortium Clinical and genetic features of cervical dystonia in a large multicenter cohort
LeDoux MS, Vemula SR, Xiao J, Thompson MM, Perlmutter JS, Wright LJ, Jinnah JA, Rosen AR, Hedera P, Comella CL, Weissbach A, Jankovic J, Barbano RL, Reich SG, Rodrigue..., Neurol Genet, 1/1/2016
The relationship between essential tremor and Parkinson’s disease
Thenganatt MA, Jankovic J, Parkinsonism Relat Disord, 1/1/2016
Deutetrabenazine in tics associated with Tourette syndrome
Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy T, Shprecher D, Stamler D, Tremor Other Hyperkinet Mov, 1/1/2016
Bolivian kindred with combined spinocerebellar ataxia types 2 and 10
Baizabal-Carvallo JF, Xia G, Botros P, Laguna J, Ashizawa T, Jankovic J, Acta Neurol Scand, 1/1/2015
Join now to see all

Books/Book Chapters

Bradley’s Neurology in Clinical Practice
Chapter: Diagnosis of Neurological Disease. Chapter 1.
Page 1 - 7Daroff RB, Jankovic J, Mazziota JC, Pomeroy SLEditors: Daroff RB, Jankovic J, Maziotta J, Pomeroy S.Butterworth-Heinemann (Elsevier), Philadelphia, PAEdition 7th,2016
Neurology secrets
Chapter: Basal ganglia disorders.
Page 137 - 148Wijemanne S, Hanna PA, Jankovic JEditors: Kass JS, Mizrahi EM.Elsevier, Philadelphia, PAEdition 6th,2016
Neurology secrets
Chapter: Movement disorders.
Page 149 - 166Wijemanne S, Hanna PA, Jankovic JEditors: Kass JS, Mizrahi EM.Elsevier, Philadelphia, PAEdition 6th,2016
Bradley’s Neurology in Clinical Practice
Chapter: Diagnosis and Assessment of Parkinson’s Disease and Other Movement disorders. Chapter 23
Page 223 - 249Jankovic J, Lang AEEditors: Daroff RB, Jankovic J, Maziotta J, Pomeroy S.Butterworth-Heinemann (Elsevier), Philadelphia, PAEdition 7th,2016
Functional Neurologic Disorders, Handbook of Clinical Neurology
Chapter: Psychogenic (functional) parkinsonism.
Page 259 - 262Thenganatt MA, Jankovic JEditors: Hallett M, Stone J, Carson A.Elsevier, Amsterdam, Netherlands2016
Bradley’s Neurology in Clinical Practice
Chapter: Laboratory Investigations in Diagnosis and Management of Neurological Disease. Chapter 33.
Page 1422 - 1460Daroff RB, Jankovic J, Mazziota JC, Pomeroy SLEditors: Daroff RB, Jankovic J, Maziotta J, Pomeroy S.Butterworth-Heinemann (Elsevier), Philadelphia, PAEdition 7th,2016
Movement Disorders in Childhood
Singer HS, Mink JW, Gilbert DL, Jankovic JButterworth-Heinemann (Elsevier), Philadelphia, PAEdition 2nd,2016
Bradley’s Neurology in Clinical Practice, Volume 1 and 2
Jankovic JEditors: Daroff RB, Jankovic J, Maziotta J, Pomeroy S.Butterworth-Heinemann (Elsevier), Philadelphia, PAEdition 7th,2016
Medication-Induced Movement Disorders
Chapter: L-dopa dyskinesias.
Page 110 - 130Ramirez-Castaneda J, Jankovic JEditors: Friedman J.Cambridge University Press2015
Merritt’s Textbook of Neurology
Chapter: Choreas.
Page 691 - 697Jankovic J, Fahn S.Editors: Louis E, Mayer S, Rowland LP.Wolters Kluwer/Lippincott Williams & WilkinsEdition 13th,2015
Movement Disorders: Genetics and Models
Chapter: Tics and Tourette syndrome: Phenomenology.
Page 705 - 712Patel N, Jankovic JEditors: Ledoux MS.Elsevier, ElsevierEdition 2nd,2015
Parkinson's Disease and Movement Disorders
Editors: Jankovic J, Tolosa E.Lippincott Williams & Wilkins, Philadelphia, PAEdition 6th,2015
Movement Disorders in Neurologic and Systemic Disease
Chapter: Principles of management in movement disorders.
Page 31 - 38Poewe W, Jankovic JEditors: Poewe W, Jankovic J.Cambridge University Press, Cambridge, United Kingdom2014
Movement Disorders in Neurologic and Systemic Disease
Chapter: Movement disorders of autoimmune origin.
Page 52 - 72Baizabal-Carvallo JF, Jankovic JEditors: Poewe W, Jankovic J.Cambridge University Press, Cambridge, United Kingdom2014
Movement Disorders in Neurologic and Systemic Disease
Chapter: Phenomenology, classification and diagnostic approach to patients with movement disorders.
Aerts MB, Jankovic J, van de Warrenburg BP, Bloem BREditors: Poewe W, Jankovic J.Cambridge University Press, Cambridge, United Kingdom2014
Geriatric Neurology
Chapter: Parkinson’s disease.
Page 315 - 324Fekete R, Jankovic JEditors: Sabbagh MN and Nair AK.Wiley2014
Movement Disorders in Neurologic and Systemic Disease
Chapter: Respiratory complications of movement disorders.
Page 398 - 418Mehanna R, Jankovic JEditors: Poewe W, Jankovic J.Cambridge University Press, Cambridge, United Kingdom2014
Handbook of Neurotoxicity
Chapter: Botulinum neurotoxins as therapeutics.
Page 553 - 590Mehanna R, Jankovic JEditors: Kostrzewa R.Springer Science Publishing2014
Movement Disorders in Neurologic and Systemic Disease
Editors: Poewe W, Jankovic J.Cambridge University Press, Cambridge, United Kingdom2014
Movement Disorders, Current Opinion in Neurology
Editors: Jankovic J.Wolters Kluwer Health/ Lippincott Williams & Wilkins, London, United Kingdom2014
Parkinson's Disease: Diagnosis, Motor Symptoms and Non-Motor Features. Clinical Insights E-Book Series
Chapter: Animal models of Parkinson’s disease.
Page 115 - 136Le W, Jankovic JEditors: Jankovic J.Future Science Group, London, United Kingdom2013
Parkinson's Disease: Diagnosis, Motor Symptoms and Non-Motor Features. Clinical Insights E-Book Series
Chapter: Differentiating Parkinson’s disease from other parkinsonian disorders.
Page 137 - 141Jankovic JEditors: Jankovic J.Future Science Group, London, United Kingdom2013
Parkinson’s Disease: Medical and Surgical Treatment. Clinical Insights E-Book Series
Chapter: Parkinson’s disease treatment pipelines.
Page 138 - 148Jankovic JEditors: Jankovic J.Future Science Group, London, United Kingdom2013
Manual of Botulinum Toxin Therapy
Chapter: The use of botulinum toxin in tic disorders and essential hand and head tremor.
Page 160 - 167Jankovic JEditors: Truong D, Dressler D, Hallett M.Cambridge University Press2013
Movement Disorders: 101 Challenging Cases
Chapter: Dystonia, ataxia, dementia and a family history of “Huntington disease”.
Page 187 - 190Jankovic JEditors: Fernandez H, Merello M.Demos Medical, New York, NY2013
Join now to see all

Abstracts/Posters

A pilot study of deutetrabenazine in tics associated with Tourette syndrome.
Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy T, Shprecher D, Stamler D, American Society of Clinical Psychopharmacology, Miami Beach, FL, 1/29/2017
Results from a phase 1b multiple ascending-dose study of PRX002, an anti–alpha-synuclein monoclonal antibody, in patients with Parkinson’s disease.
Jankovic J, Goodman I, Safirstein B, Schenk D, Kinney GG, Koller M, Ness DK, Griffith SG, Grundman M, Soto J, Ostrowitzki S, Boess FG, Martin-Facklam M, Quinn JF, Isaa..., 3rd EAN Congress, Amsterdam, The Netherlands, 1/27/2017
A phase 2, openlabel, dose-escalating study to evaluate the safety and preliminary efficacy of daxibotulinumtoxinA for injection (RT002) in isolated cervical dystonia.
Comella CL, Brashear A, Jankovic J, Patel AT, Truong DD, Chung CY, Rubio RG, 69th Annual Meeting of the AAN, Boston, MA, 1/22/2017
Clinical relevance of treatment with onabotulinumtoxinA in patients with cervical dystonia: Results from the CD Probe study.
Mari Z, Dashtipour K, Jankovic J, Adler CH, Schwartz M, Brin MF, 69th Annual Meeting of the AAN, Boston, MA, 1/22/2017
Assessment of capacity to consent in a Huntington disease clinical trial: Implications for future clinical trial design in neurodegenerative disease populations.
Testa C, Edmondson M, Agarwal P, Blindauer K, Gray C, Jankovic J, Kumar R, Shprecher D, Siragusa P, Whaley J, Frank S for the Huntington Study Group First-HD and ARC-H..., 69th Annual Meeting of the AAN, Boston, MA, 1/22/2017
A phase 2, openlabel, dose-escalating study to evaluate the safety and preliminary efficacy of Daxibotulinumtoxina for injection (RT002) in isolated cervical dystonia.
Comella CL, Brashear A, Jankovic J, Patel AT, Truong DD, Chung CY, Rubio RG, 21st International Congress of Parkinson’s Disease and Movement Disorders, Vancouver, Canada, 1/8/2017
Clinical relevance of treatment with onabotulinumtoxina in patients with cervical dystonia: results from the CD PROBE study.
Dashtipour K, Mari Z, Jankovic J, Adler CH, Schwartz M, Brin MF, 21st International Congress of Parkinson’s Disease and Movement Disorders, Vancouver, Canada, 1/8/2017
A randomized, double-blind, placebo-controlled study of the D1 receptor antagonist ecopipam for children and adolescents with Tourette syndrome.
Gilbert DL, Murphy T, Jankovic J, Budman CL, Black KJ, Kurlan R, Coffman KA, McCracken J, Juncos J, Grant J, and Chipkin RE, 21st International Congress of Parkinson’s Disease and Movement Disorders, Vancouver, Canada, 1/8/2017
Leg stereotypy disorder: Clinical characteristics and prevalence.
Jankovic J, Lotia M, York MK, Strutt AM, 21st International Congress of Parkinson’s Disease and Movement Disorders, Vancouver, Canada, 1/7/2017
Emotion regulation and cognitive functioning in psychogenic patients.
Scott BM, Strutt AM, Lundberg-Love P, Schmitt AL, Jankovic J, Bowers D, 21st International Congress of Parkinson’s Disease and Movement Disorders, Vancouver, Canada, 1/7/2017
Whole exome sequencing in essential tremor.
Alfradique-Dunham I, Robak LA, Kaw A, Fagbongbe OI, Coban Akdemir Z, Young E, Lupski J, Jankovic J, Shulman JM, 21st International Congress of Parkinson’s Disease and Movement Disorders, Vancouver, Canada, 1/6/2017
Treatable rare movement disorders.
Rare Movement Disorders Study Group (Jankovic J), 21st International Congress of Parkinson’s Disease and Movement Disorders, Vancouver, Canada, 1/6/2017
Hemidystonia associated with Alexander disease.
Vijayakumar D, Lewis RA, Fuller GN, Dhar SU, Machol K, Robak L, Jankovic J, 21st International Congress of Parkinson's Disease and Movement Disorders, Vancouver, Canada, 1/6/2017
Results from a phase 1b multiple ascending-dose study of PRX002, an anti–alpha-synuclein monoclonal antibody, in patients with Parkinson’s disease.
Jankovic J, Goodman I, Safirstein B, Schenk D, Kinney GG, Koller M, Ness DK, Griffith SG, Grundman M, Soto J, Ostrowitzki S, Boess FG, Martin-Facklam M, Quinn JF, Isaa..., Neurodegener Dis; 13th International Conference on Alzheimer’s and Parkinson’s Disease, Vienna, Austria, 1/1/2017
A pilot study of deutetrabenazine in tics associated with Tourette syndrome.
Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy T, Shprecher D, Stamler D, 63rd Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New York, NY, 1/27/2016
Movement Disorders. Objectives of the rare movement disorders study group.
Gatto EM, Albanese A, Bathia K, Cardoso F, Cesarini M, Chade A, Chana P, De la Cerda A, Espay A, Etcheverry J, Ferreira J, Garcia Ruiz P, Jankovic J, Jinnah HA, Kaji R..., 20th International Congress of Parkinson’s Disease and Movement Disorders, Berlin, Germany, 1/23/2016
Predictors of onabotulinumtoxinA treatment response in patients with cervical dystonia.
Jankovic J, Schwartz M, Adams AM, 20th International Congress of Parkinson’s Disease and Movement Disorders, Berlin, Germany, 1/23/2016
Treatment of blepharospasm with apraclonidine.
Vijayakumar D, Wijemanne S, Jankovic J, 20th International Congress of Parkinson's Disease and Movement Disorders, Berlin, Germany, 1/23/2016
Apraclonidine in the treatment of ptosis.
Wijemanne S, Vijayakumar D, Jankovic J, 20th International Congress of Parkinson's Disease and Movement Disorders, Berlin, Germany, 1/23/2016
A pilot study of deutetrabenazine in tics associated with Tourette syndrome.
Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy T, Shprecher D, Stamler D, 20th International Congress of Parkinson's Disease and Movement Disorders, Berlin, Germany, 1/21/2016
A pilot study of deutetrabenazine in tics associated with Tourette syndrome.
Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy T, Shprecher D, Stamler D, 68th Annual Meeting of the AAN, Vancouver, British Columbia, Canada, 1/16/2016
A phase 2, openlabel, dose-escalating study to evaluate the safety and preliminary efficacy of Daxibotulinumtoxina for injection (RT002) in isolated cervical dystonia.
Comella CL, Brashear A, Jankovic J, Patel AT, Truong DD, Chung CY, Rubio RG, Toxicon; TOXINS Congress, Madrid, Spain, 1/1/2016
Clinical relevance of treatment with onabotulinumtoxina in patients with cervical dystonia: results from the CD PROBE study.
Dashtipour K, Mari Z, Jankovic J, Adler CH, Schwartz M, Brin MF, Toxicon; TOXINS Congress, Madrid, Spain, 1/1/2016
Potential new uses of botulinum toxin injections in movement disorders.
Jankovic J, Toxicon; TOXINS Congress, Madrid, Spain, 1/1/2016
Predictors of onabotulinumtoxina response in patients with cervical dystonia.
Jankovic J, Schwartz M, Adams AM, Toxicon; TOXINS Congress, Madrid, Spain, 1/1/2016
Join now to see all

Lectures

New Uses of Botulinum Toxin in Movement Disorders
Madrid, Spain - 1/18/2017
Dyskinesia: What to do about moving too much?
1/21/2016
Cannabis in Parkinson’s disease
Charlotte, NC - 1/5/2016
Post-traumatic dystonia and complex regional pain syndrome
Rockville, MD - 1/2/2016
Hyperkinetic Movement Disorders
Cartagena, Colombia - 1/24/2015
The role of a mentor in life and in career
Berlin, Germany - 1/23/2015
Autoimmune Movement Disorders
Berlin, Germany - 1/23/2015
Beyond Shaking and Slowness
1/2/2015
Innovations in Parkinson’s Disease: Past, present & Future
Houston, TX - 1/10/2014
Current Neurology
Baylor College of Medicine, Houston, TX - 1/1/2014
23rd Annual Course: A Comprehensive Review of Movement Disorders for the Clinical Practitioner
Columbia University, Aspen, Colorado - 7/28/2013
Comprehensive Board Review of Movement Disorders for the Clinical Practitioner
Columbia University, Aspen, Colorado - 7/30/2012
Advances in Movement Disorders
New York, NY - 1/25/2012
Parkinson’s Disease and Movement Disorders: Moving Forward, Breaking Boundaries
Baylor College of Medicine - 1/1/2010
Tetrabenazine: Pharmacology and Clinical Use
Baltimore, MD - 1/20/2009
Huntinton’s Disease: The past, present and future.
Cleveland, OH - 1/16/2009
Parkinson’s Disease: Breakthrough Research and Treatments
Baylor College of Medicine, Houston, TX - 1/11/2009
An Update on Tourette Syndrome
Baylor College of Medicine, Houston, TX - 1/5/2009
Treatment of Parkinson’s Disease
1/1/2009
Pre-clinical Biomarkers and Modifiers of Parkinson’s Disease
Houston, TX - 1/18/2008
Multidiciplinary Advances in Tourette’s Syndrome and Implicatios for Clinical Practice
Bari, Italy - 1/4/2008
Is Levodopa the Magic Bullet for Parkinson’s Disease?
Nurnberg, Germany - 1/4/2008
NYU Neurology Day 2008
New York, NY - 1/3/2008
Updates for Neurologists
New York, NY - 1/3/2008
Clinical usefulness of botulinum toxin
1/1/2008
Join now to see all

Other

Skin in Parkinson’s disease.
Jankovic J, HAPS Newsletter
1/1/2017
Hypokinetic movement disorders.
Jankovic J, UpToDate in Pediatrics
http://www.uptodateonline.com
Wellesley, MA - 1/1/2017
Hyperkinetic movement disorders.
Jankovic J, UpToDate in Pediatrics
http://www.uptodateonline.com
Wellesley, MA - 1/1/2017
Etiology and pathogenesis of Parkinson's disease.
Jankovic J, UpToDate in Neurology
Wellesley, MA - 1/1/2017
Orthostatic Tremor Resource
Jankovic J
http://www.orthostatictremor.org/
Houston, TX - 1/10/2016
Parkinson’s disease and music.
Jankovic J., HAPS Happening Newsletter
1/1/2016
Eldad Melamed. In Memoriam.
Jankovic J, Moving Along
1/1/2015
Marijuana and Parkinson’s disease.
Jankovic J, HAPS Newsletter
1/1/2015
NKX2-1-Related Disorders.
Patel NJ, Jankovic J (Pagon RA, Adam MP, Bird TD, et al., editors), GeneReviews
http://www.ncbi.nlm.nih.gov/books/NBK185066/
University of Washington, Seattle, WA - 1/20/2014
Huntington’s disease
Jankovic J, Aspen Course on Parkinson’s Disease and Other Movement Disorders
http://www.medscape.org/viewarticle/839235
1/1/2014
Ha A, Jankovic J
Ha A, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
www.medlink.com
San Diego, CA - 1/1/2013
Spasmodic dysphonia.
Ha A, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
www.medlink.com
San Diego, CA - 1/1/2013
Parkinson’s Disease: Diagnosis, Motor Symptoms and Non-Motor Features. Clinical Insights E-Book Series
Jankovic J, ed, Future Science Group
www.futuremedicine.com
London, United Kingdom - 1/1/2013
Parkinson’s Disease: Medical and Surgical Treatment. Clinical Insights E-Book Series
Jankovic J, ed, Future Science Group
www.futuremedicine.com
London, United Kingdom - 1/1/2013
Hemifacial Spasm.
Yaltho TC, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
www.medlink.com
San Diego, CA - 1/1/2012
Paroxysmal dyskinesias.
Ha A, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
www.medlink.com
San Diego, CA - 1/1/2012
Corticobasal degeneration.
Frank SA, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
www.medlink.com
San Diego, CA - 1/1/2012
Functional anatomy and pharmacology of the basal ganglia.
Hanna PA, Onasanya O, Mink J, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
www.medlink.com
San Diego, CA - 1/1/2012
Motor control and movement disorders
Tanquilli RM and Jankovic J, Neurology-Medlink, Arbor Publishing
http://medlink.com
La Jolla, CA - 1/1/2012
Childhood movement disorders.
Jimenez-Shahed J, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
www.medlink.com
San Diego, CA - 1/1/2012
Movement disorders emergencies.
Patel N, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
www.medlink.com
San Diego, CA - 1/1/2012
Neuro-ophthalmology of movement disorders.
Waln O, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
www.medlink.com
San Diego, CA - 1/1/2012
Voice tremor.
Jankovic J, Tremor Talk (Newsletter of IETF), Fall/Winter
1/1/2010
Review of Editor’s Choice Article “Imaging Essential Tremor”
Jankovic J, Web Podcast
http://www.movementdisorders.org
1/1/2010
Dopa-responsive dystonia.
Yaltho TC, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
www.medlink.com
San Diego, CA - 1/1/2010
Join now to see all

Press Mentions

Syn-One Test Can Diagnose Parkinson’s via Skin BiopsyMay 9th, 2023
AAN 2023: Skin Test Ably Detects Alpha-Synuclein Clumps in TrialMay 2nd, 2023
Revance to Showcase Data from Phase 3 ASPEN-1 Clinical Trial Evaluating Efficacy, Duration of Effect and Safety of DaxibotulinumtoxinA for Injection for Cervical Dystonia at International Parkinson and Movement Disorder Society Virtual Congress 2021September 16th, 2021
Join now to see all